CorMedix Inc (NASDAQ: CRMD) is 3.72% higher on its value in year-to-date trading and has touched a low of $2.57 and a high of $6.09 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $3.42 in the last trading session, with the day’s gains setting it 0.48%.
Currently trading at $3.90, the stock is 14.00% and 16.38% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing 14.04% at the moment leaves the stock 2.90% off its SMA200. CRMD registered 7.73% gain for a year compared to 6-month loss of -2.26%. The firm has a 50-day simple moving average (SMA 50) of $3.79k and a 200-day simple moving average (SMA200) of -$3.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 18.54% gain in the last 1 month and extending the period to 3 months gives it a 18.54%, and is 8.64% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.28% over the week and 4.97% over the month.
CorMedix Inc (CRMD) has around 82 employees, a market worth around $213.76M and $0.00M in sales. Distance from 52-week low is 51.75% and -35.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.58%).
CorMedix Inc quarterly earnings per share for the current quarter are estimated at -$0.29.The EPS is expected to grow by 18.55% this year
129 institutions hold shares in CorMedix Inc (CRMD), with institutional investors hold 34.82% of the company’s shares. The shares outstanding are 54.94M, and float is at 53.71M with Short Float at 14.37%. Institutions hold 34.31% of the Float.
The top institutional shareholder in the company is Nomura Holdings Inc. with over 2.95 million shares valued at $11.7 million. The investor’s holdings represent 5.39% of the CRMD Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 2.72 million shares valued at $10.8 million to account for 4.97% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 2.55 million shares representing 4.66% and valued at over $10.12 million, while Elliott Investment Management L.p. holds 2.83% of the shares totaling 1.55 million with a market value of $6.15 million.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by DUNTON ALAN W, the company’s Director. SEC filings show that DUNTON ALAN W bought 3,000 shares of the company’s common stock on Dec 15 ’23 at a price of $3.30 per share for a total of $9900.0. Following the purchase, the insider now owns 15250.0 shares.
CorMedix Inc disclosed in a document filed with the SEC on Dec 14 ’23 that DUNTON ALAN W (Director) bought a total of 3,000 shares of the company’s common stock. The trade occurred on Dec 14 ’23 and was made at $3.45 per share for $10350.0. Following the transaction, the insider now directly holds 12250.0 shares of the CRMD stock.
Still, SEC filings show that on Nov 17 ’23, Mistry Erin (Chief Commercial Officer) acquired 1,000 shares at an average price of $4.00 for $4000.0. The insider now directly holds 4,900 shares of CorMedix Inc (CRMD).
